Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMycelx Di Regulatory News (MYX)

Share Price Information for Mycelx Di (MYX)

Share Price is delayed by 15 minutes
Get Live Data
60.50    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 3.00 (5.085%)
Market Cap: £14.74m
MYX Live PriceLast checked at - London Stock Exchange

Intraday Mycelx Di Share Chart

Trading Update

30 Jan 2017 07:00

RNS Number : 3696V
MyCelx Technologies Corporation
30 January 2017
 

 

30 January 2017

MYCELX TECHNOLOGIES CORPORATION (AIM: MYX)

("MYCELX" or the "Company")

Trading Update

MYCELX Technologies Corporation (AIM: MYX), the provider of patented water treatment solutions for the oil and gas and commercial industrial markets worldwide, is pleased to provide a Trading Update.

Throughout 2016, MYCELX continued to demonstrate good operational progress with a recent contract award for a fifth installation of offshore water treatment equipment for a current customer. Additionally, MYCELX commissioned its fourth water treatment system servicing terminals on the Houston Ship Channel and expects the subsequent media sales to begin in 2017.

 

The Board is confident that it will be able to report results for the full year ended 31 December 2016 which are in line with market expectations, and show MYCELX having successfully achieved an operationally cash flow neutral position, in line with its stated target.

 

Since announcing its exclusive marketing and distribution agreement with Schlumberger in June 2016, both companies have collaborated to organize the global marketing initiative that was launched in 4Q 2016 and has been presented in six countries to date. This targeted engagement with industry decision makers is expected to lead to the deployment of MYCELX proprietary water treatment systems, in particular MYCELX's RE-GEN product for the upstream market. Whilst it is too early to forecast the likely 2017 revenue contribution, the pipeline is growing and joint proposal activity is increasing.

 

Overall, the MYCELX contracted order book is stronger than this time last year and the Company therefore envisages a year-on-year revenue increase for 2017 in the range of 30%, with the aim of being EBITDA neutral, and with no material change in cash balance. MYCELX's revenue is already being generated from a broader geographic base than previously. The Company fully expects this positive trend, which is a result of our deliberate efforts to broaden our geographic exposure, to continue.

 

As is widely reported, the investment climate remains uncertain and, consequently, forecasting with any degree of accuracy remains challenging. As such, we will continue to adopt a prudent approach to expenditure, whilst continuing the encouraging international sales and marketing efforts.

 

MYCELX will be providing further guidance at the time of its results for the year ended 31 December 2016, expected to be announced in May 2017.

 

 

Commenting on today's Trading Update, Connie Mixon, CEO, said:

 

"MYCELX's world leading clean water technology solutions continue to gain traction into its core market of the oil & gas sector, and increasingly beyond. Our partnership with Schlumberger is progressing well with the global marketing initiative currently underway. We are also pleased to update on other important operational milestones, such as our further work with a repeat global oil and gas customer. Our progress as a business is firmly underpinned by industry's requirement for innovative technologies to manage their water requirements. We are providing a service that not only significantly enhances the economics of our clients' projects, but that also ensures improved operational efficiencies and performance."

 

"We are pleased to confirm that we will meet guidance for 2016. Looking ahead, this year is expected to continue to show an improved financial performance. However, market uncertainty remains the reality and accurate 2017 full year guidance remains difficult at this stage. That said, we are encouraged by the levels of interest and that the order book is currently ahead of where it was at the same time last year."

 

For further information please contact: 

MYCELX Technologies Corporation

Connie Mixon, CEO

Kim Slayton, CFO

 

Tel: +1 888 306 6843

Cantor Fitzgerald Europe - Nomad and Broker

Andrew Craig

Richard Salmond

 

Tel: +44 20 7894 7000

Celicourt Communications

 Mark Antelme

Joanna Boon

 

Tel: +44 20 7520 9266

 

Certain information contained in this announcement would have constituted inside information (as defined by Article 7 of Regulation (EU) No 596/2014) prior to its release as part of this announcement.

Notes to Editors

MYCELX is a revolutionary oil-free water technology company solving the world's toughest oil removal problems in the oil and gas industry. The systems are based upon scientific breakthrough for a completely different approach to permanent oil removal. The Company created the patented MYCELX polymer using innovative molecular cohesion for removing oil from water far beyond what conventional systems have ever achieved. MYCELX systems remove oil to critically low levels in a much smaller physical footprint than conventional systems and in a virtually fail-safe process.

www.mycelx.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTOKODKPBKDNDB
Date   Source Headline
8th Oct 20187:00 amRNSNew Project Award and Trading Update
12th Sep 20187:00 amRNSHalf Year Results Statement
27th Jul 20187:00 amRNSContract Extension in Saudi Arabia
11th Jul 20181:16 pmRNSResult of Annual Meeting
7th Jun 20184:23 pmRNSBlock listing Interim Review
7th Jun 20183:42 pmRNSAnnual Financial Report
15th May 20187:00 amRNSFinal Results for the year ending 31 December 2017
19th Apr 20187:00 amRNSNew Purchase Order Award and Equipment Sale
13th Apr 201810:18 amRNSIssue of Equity
10th Apr 20187:00 amRNSPurchase Order Award & General Manager Appointment
28th Mar 201812:48 pmRNSHolding(s) in Company
16th Feb 20187:00 amRNSIssue of Equity
6th Feb 20187:00 amRNSExtension of Contract and New Project
17th Jan 20187:00 amRNSTrading Update
7th Dec 20179:46 amRNSBlock listing Interim Review
3rd Nov 201712:39 pmRNSIssue of Equity
26th Oct 20177:30 amRNSHolding(s) in Company
9th Oct 20177:00 amRNSIssue of Equity
27th Sep 20172:44 pmRNSApplication for Block Admission
26th Sep 20175:31 pmRNSClosure of Restricted Stock Line
21st Sep 20177:00 amRNSConsolidation of Stock Lines
13th Sep 20177:00 amRNSHalf Year Results Statement
12th Jul 201712:30 pmRNSResult of Annual Meeting
7th Jul 20177:00 amRNSHalf Year Trading Update
9th Jun 201710:00 amRNSMailing of Annual Financial Report & GM Notice
7th Jun 201710:30 amRNSBlock listing Interim Review
30th May 20171:19 pmRNSDirector/PDMR Shareholding
26th May 20177:00 amRNSContract win with new SABIC affiliate customer
11th May 20177:00 amRNSFinal Results for the year ending 31 December 2016
8th May 20177:00 amRNSContract Award & Notification of Full Year Results
30th Jan 20177:00 amRNSTrading Update
7th Dec 20162:34 pmRNSBlock listing Interim Review
4th Oct 20167:00 amRNSAppointment of Nominated Adviser & Broker
14th Sep 20167:00 amRNSHalf Year Results Statement
13th Jul 20164:21 pmRNSResult of AGM
11th Jul 20167:00 amRNSHalf Year Trading Update
30th Jun 20167:00 amRNSHolding(s) in Company
24th Jun 20167:00 amRNSMyCelx and Schlumberger Sign Upstream Agreement
9th Jun 20167:00 amRNSMailing of 2015 Annual Report and Notice of AGM
7th Jun 20163:32 pmRNSBlock listing Interim Review
17th May 20167:00 amRNSFinal Results
16th Mar 20167:00 amRNSAppointment of CFO/Grant of Share Options
4th Mar 20161:25 pmRNSHolding(s) in Company
4th Mar 20167:00 amRNSTrading Update
11th Jan 20165:30 pmRNSHolding(s) in Company
29th Dec 20152:23 pmRNSHolding(s) in Company
18th Dec 201510:13 amRNSHolding(s) in Company
15th Dec 20155:25 pmRNSHolding(s) in Company
15th Dec 20155:24 pmRNSHolding(s) in Company
11th Dec 20157:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.